This could have serious implications for the medical device market, and analysts recently reduced growth predictions for orthopedic and cardiac device companies. The Reuters report quoted Michael Matson, an analyst with Mizuho Securities who reduced his growth forecast for hip and knee procedures from 3 percent to 1 percent for 2012.
Related Articles about the Medical Devices Market:
Hospitals, Health Groups Leverage Purchasing Power for Greener Medical Supplies
Prescription Sales Through Primary Healthcare Distributors Reached $268 Billion
Funding Cutbacks, Complex Device Approval Process Threaten Med Tech Industry
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
